Literature DB >> 20334569

Analysis of RT sequences of subtype C HIV-type 1 isolates from indian patients at failure of a first-line treatment according to clinical and/or immunological WHO guidelines.

Alaka Deshpande1, Anne Cécile Jeannot, Marie Hélène Schrive, Linda Wittkop, Patricia Pinson, Hervé J Fleury.   

Abstract

The reverse transcriptase (RT) sequences of HIV-1 subtype C isolates from Indian patients at failure (according to WHO clinical or immunological criteria) of a first-line treatment including d4T/AZT-3TC-NVP/EFV were compared to those of HIV-1 isolates from naive patients and analyzed for drug resistance mutations (DRMs), which were interpreted according to ANRS and Stanford algorithms. All viruses were of subtype C. We have observed a decrease of the polymorphism at positions 36 and 214 of RT while D121Y, V179I, and Q217E could be new DRMs. Numerous crucial DRMs to NRTIs and NNRTIs could be recorded including TAMs of pathway 1 and K65R. According to both algorithms, the accumulation of DRMs may induce resistance to second-line NRTIs including tenofovir.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20334569     DOI: 10.1089/aid.2009.0217

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  12 in total

Review 1.  Systematic review of HIV drug resistance in Southeast Asia.

Authors:  Andrew B Trotter; Steven Y Hong; Padmini Srikantiah; Iyanthi Abeyewickreme; Silvia Bertagnolio; Michael R Jordan
Journal:  AIDS Rev       Date:  2013 Jul-Sep       Impact factor: 2.500

2.  Case report of the rare deletion at codon 69 of reverse transcriptase in a South African HIV-1 subtype C infected patient.

Authors:  Carole L Wallis; Willem D F Venter; Wendy S Stevens; Maria A Papathanasopoulos
Journal:  Virus Genes       Date:  2010-12       Impact factor: 2.332

3.  Drug resistance patterns and virus re-suppression among HIV-1 subtype C infected patients receiving non-nucleoside reverse transcriptase inhibitors in South Africa.

Authors:  Ziad El-Khatib; Allison K Delong; David Katzenstein; Anna Mia Ekstrom; Johanna Ledwaba; Lerato Mohapi; Fatima Laher; Max Petzold; Lynn Morris; Rami Kantor
Journal:  J AIDS Clin Res       Date:  2011-02-18

4.  A template-dependent dislocation mechanism potentiates K65R reverse transcriptase mutation development in subtype C variants of HIV-1.

Authors:  Dimitrios Coutsinos; Cédric F Invernizzi; Daniela Moisi; Maureen Oliveira; Jorge L Martinez-Cajas; Bluma G Brenner; Mark A Wainberg
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

5.  Role of HIV Subtype Diversity in the Development of Resistance to Antiviral Drugs.

Authors:  Mark A Wainberg; Bluma G Brenner
Journal:  Viruses       Date:  2010-11-11       Impact factor: 5.048

6.  Resistance patterns selected by nevirapine vs. efavirenz in HIV-infected patients failing first-line antiretroviral treatment: a bayesian analysis.

Authors:  Nicole Ngo-Giang-Huong; Gonzague Jourdain; Billy Amzal; Pensiriwan Sang-a-gad; Rittha Lertkoonalak; Naree Eiamsirikit; Somboon Tansuphasawasdikul; Yuwadee Buranawanitchakorn; Naruepon Yutthakasemsunt; Sripetcharat Mekviwattanawong; Kenneth McIntosh; Marc Lallemant
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

7.  K65R in subtype C HIV-1 isolates from patients failing on a first-line regimen including d4T or AZT: comparison of Sanger and UDP sequencing data.

Authors:  Patricia Recordon-Pinson; Jennifer Papuchon; Sandrine Reigadas; Alaka Deshpande; Hervé Fleury
Journal:  PLoS One       Date:  2012-05-16       Impact factor: 3.240

Review 8.  Drug resistance in non-B subtype HIV-1: impact of HIV-1 reverse transcriptase inhibitors.

Authors:  Kamalendra Singh; Jacqueline A Flores; Karen A Kirby; Ujjwal Neogi; Anders Sonnerborg; Atsuko Hachiya; Kalyan Das; Eddy Arnold; Carole McArthur; Michael Parniak; Stefan G Sarafianos
Journal:  Viruses       Date:  2014-09-24       Impact factor: 5.048

9.  Evaluation of WHO immunologic criteria for treatment failure: implications for detection of virologic failure, evolution of drug resistance and choice of second-line therapy in India.

Authors:  Snigdha Vallabhaneni; Sara Chandy; Elsa Heylen; Maria L Ekstrand
Journal:  J Int AIDS Soc       Date:  2013-06-03       Impact factor: 5.396

10.  The Impact of HIV Genetic Polymorphisms and Subtype Differences on the Occurrence of Resistance to Antiretroviral Drugs.

Authors:  Mark A Wainberg; Bluma G Brenner
Journal:  Mol Biol Int       Date:  2012-06-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.